<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000662457"><TermName>COPP regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat Hodgkin and non-Hodgkin lymphomas. It includes the drugs cyclophosphamide, vincristine sulfate (Oncovin), procarbazine hydrochloride, and prednisone. Also called COPP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726236" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;COPP regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726237" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen COPP&quot;" language="es" id="_4"/><SpanishTermName>régimen COPP</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de un régimen de quimioterapia combinada que se usa para tratar linfomas de Hodgkin y no Hodgkin. Incluye los medicamentos ciclofosfamida, sulfato de vincristina (Oncovin), clorhidrato de procarbazina y prednisona. También se llama COPP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-04-23</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000686548">COPP</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
